SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001082554-23-000033
Filing Date
2023-11-01
Accepted
2023-11-01 06:05:10
Documents
14
Period of Report
2023-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K uthr-20231101.htm   iXBRL 8-K 30272
2 EX-99.1 uthrq32023-ex991.htm EX-99.1 194960
6 GRAPHIC ut_lungiconxredxlogoa.jpg GRAPHIC 13650
  Complete submission text file 0001082554-23-000033.txt   384115

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20231101.xsd EX-101.SCH 1939
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20231101_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20231101_pre.xml EX-101.PRE 12544
8 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20231101_htm.xml XML 2728
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 231366412
SIC: 2834 Pharmaceutical Preparations